Presenilin-1 polymorphism and Alzheimer's disease.
Publication
, Journal Article
Scott, WK; Growdon, JH; Roses, AD; Haines, JL; Pericak-Vance, MA
Published in: Lancet
April 27, 1996
Duke Scholars
Published In
Lancet
ISSN
0140-6736
Publication Date
April 27, 1996
Volume
347
Issue
9009
Start / End Page
1186 / 1187
Location
England
Related Subject Headings
- Risk Factors
- Presenilin-1
- Polymorphism, Genetic
- Point Mutation
- Middle Aged
- Membrane Proteins
- Humans
- Homozygote
- General & Internal Medicine
- Alzheimer Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Scott, W. K., Growdon, J. H., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1996). Presenilin-1 polymorphism and Alzheimer's disease. Lancet, 347(9009), 1186–1187.
Scott, W. K., J. H. Growdon, A. D. Roses, J. L. Haines, and M. A. Pericak-Vance. “Presenilin-1 polymorphism and Alzheimer's disease.” Lancet 347, no. 9009 (April 27, 1996): 1186–87.
Scott WK, Growdon JH, Roses AD, Haines JL, Pericak-Vance MA. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 1996 Apr 27;347(9009):1186–7.
Scott, W. K., et al. “Presenilin-1 polymorphism and Alzheimer's disease.” Lancet, vol. 347, no. 9009, Apr. 1996, pp. 1186–87.
Scott WK, Growdon JH, Roses AD, Haines JL, Pericak-Vance MA. Presenilin-1 polymorphism and Alzheimer's disease. Lancet. 1996 Apr 27;347(9009):1186–1187.
Published In
Lancet
ISSN
0140-6736
Publication Date
April 27, 1996
Volume
347
Issue
9009
Start / End Page
1186 / 1187
Location
England
Related Subject Headings
- Risk Factors
- Presenilin-1
- Polymorphism, Genetic
- Point Mutation
- Middle Aged
- Membrane Proteins
- Humans
- Homozygote
- General & Internal Medicine
- Alzheimer Disease